Literature DB >> 29100623

Pathogenesis of deep endometriosis.

Stephan Gordts1, Philippe Koninckx2, Ivo Brosens3.   

Abstract

The pathophysiology of (deep) endometriosis is still unclear. As originally suggested by Cullen, change the definition "deeper than 5 mm" to "adenomyosis externa." With the discovery of the old European literature on uterine bleeding in 5%-10% of the neonates and histologic evidence that the bleeding represents decidual shedding, it is postulated/hypothesized that endometrial stem/progenitor cells, implanted in the pelvic cavity after birth, may be at the origin of adolescent and even the occasionally premenarcheal pelvic endometriosis. Endometriosis in the adolescent is characterized by angiogenic and hemorrhagic peritoneal and ovarian lesions. The development of deep endometriosis at a later age suggests that deep infiltrating endometriosis is a delayed stage of endometriosis. Another hypothesis is that the endometriotic cell has undergone genetic or epigenetic changes and those specific changes determine the development into deep endometriosis. This is compatible with the hereditary aspects, and with the clonality of deep and cystic ovarian endometriosis. It explains the predisposition and an eventual causal effect by dioxin or radiation. Specific genetic/epigenetic changes could explain the various expressions and thus typical, cystic, and deep endometriosis become three different diseases. Subtle lesions are not a disease until epi(genetic) changes occur. A classification should reflect that deep endometriosis is a specific disease. In conclusion the pathophysiology of deep endometriosis remains debated and the mechanisms of disease progression, as well as the role of genetics and epigenetics in the process, still needs to be unraveled.
Copyright © 2017 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep endometriosis; classification; epigenetics; genetics; heredity; neonatal menstruation; pathogenesis

Mesh:

Year:  2017        PMID: 29100623     DOI: 10.1016/j.fertnstert.2017.08.036

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  37 in total

1.  Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020).

Authors:  Stefanie Burghaus; Sebastian D Schäfer; Matthias W Beckmann; Iris Brandes; Christian Brünahl; Radek Chvatal; Jan Drahoňovský; Wojciech Dudek; Andreas D Ebert; Christine Fahlbusch; Tanja Fehm; Peter Martin Fehr; Carolin C Hack; Winfried Häuser; Katharina Hancke; Volker Heinecke; Lars-Christian Horn; Christian Houbois; Christine Klapp; Heike Kramer; Harald Krentel; Jan Langrehr; Heike Matuschewski; Ines Mayer; Sylvia Mechsner; Andreas Müller; Armelle Müller; Michael Müller; Peter Oppelt; Thomas Papathemelis; Stefan P Renner; Dietmar Schmidt; Andreas Schüring; Karl-Werner Schweppe; Beata Seeber; Friederike Siedentopf; Horia Sirbu; Daniela Soeffge; Kerstin Weidner; Isabella Zraik; Uwe Andreas Ulrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

2.  Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruation†.

Authors:  Aya Tal; Reshef Tal; Nicola Pluchino; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

3.  Archimetrosis: the evolution of a disease and its extant presentation : Pathogenesis and pathophysiology of archimetrosis (uterine adenomyosis and endometriosis).

Authors:  Gerhard Leyendecker; Ludwig Wildt; Matthias W Laschke; Gerhard Mall
Journal:  Arch Gynecol Obstet       Date:  2022-05-21       Impact factor: 2.344

4.  SIRT1 upregulation promotes epithelial-mesenchymal transition by inducing senescence escape in endometriosis.

Authors:  Minghua Wang; Yongqi Wu; Yunbiao He; Jing Liu; Yingxing Chen; Jieqiong Huang; Guolong Qi; Ping Li
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

5.  Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis.

Authors:  Jane B Maoga; Muhammad A Riaz; Agnes N Mwaura; Georgios Scheiner-Bobis; Ezekiel Mecha; Charles O A Omwandho; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Diagnostics (Basel)       Date:  2022-03-22

Review 6.  Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis.

Authors:  Jiaxing He; Weiqin Chang; Chunyang Feng; Manhua Cui; Tianmin Xu
Journal:  Int J Genomics       Date:  2018-03-27       Impact factor: 2.326

7.  Effect of neuromuscular electrical stimulation for endometriosis-associated pain: A retrospective study.

Authors:  Xue-Ling Bi; Cai-Xia Xie
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 8.  The Burden of Endometriosis on Women's Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing.

Authors:  Luigi Della Corte; Claudia Di Filippo; Olimpia Gabrielli; Sabrina Reppuccia; Valentina Lucia La Rosa; Rosalia Ragusa; Michele Fichera; Elena Commodari; Giuseppe Bifulco; Pierluigi Giampaolino
Journal:  Int J Environ Res Public Health       Date:  2020-06-29       Impact factor: 3.390

9.  Hidrox® and Endometriosis: Biochemical Evaluation of Oxidative Stress and Pain.

Authors:  Marika Cordaro; Angela Trovato Salinaro; Rosalba Siracusa; Ramona D'Amico; Daniela Impellizzeri; Maria Scuto; Maria Laura Ontario; Livia Interdonato; Roberto Crea; Roberta Fusco; Salvatore Cuzzocrea; Rosanna Di Paola; Vittorio Calabrese
Journal:  Antioxidants (Basel)       Date:  2021-05-04

10.  Localization of claudin-2 and claudin-3 in eutopic and ectopic endometrium is highly similar.

Authors:  Alena Hoerscher; Fabian Horné; Raimund Dietze; Eniko Berkes; Frank Oehmke; Hans-Rudolf Tinneberg; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Arch Gynecol Obstet       Date:  2020-03-05       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.